A concerning shortage of Adderall, one of the drugs commonly used to treat attention deficit hyperactivity disorder (ADHD), is putting patients at risk. What caused it, and how can we fix it? The EPA has set new guidelines to keep PFAS out of drinking water. There's a problem, however: the agency's standards are absurd.

Join host Cameron English as he sits down with Dr. Chuck Dinerstein to break down these stories on Episode 40 of the Science Dispatch podcast:

The shortage of Adderall, an important medication used to treat ADHD – attention deficit/hyperactivity disorder – is a story of supply, demand, the invisible hand of market forces. It’s also about a bureaucracy focused on regulation rather than outcome. It has all the hallmarks of the opioid crisis. We have learned nothing.

With much fanfare, the EPA announced the proposed drinking water regulations for two “forever chemicals,” PFOA and PFOS. EPA Administrator Michael Regan said, “Communities across the country have suffered far too long from the ever-present threat of PFAS pollution. That is why President Biden launched a whole-of-government approach to aggressively confront these harmful chemicals, and EPA is leading the way forward.”